within Pharmacolibrary.Drugs.ATC.P;

model P03BX03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.005,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Dibutylphthalate (DBP) is an organic compound used primarily as a plasticizer in the manufacture of plastics and other products. It is not considered a therapeutic drug for human use and does not have current approval for medical indications. In the past, it has been investigated for potential pharmaceutical and agricultural applications, but concerns about toxicity have limited human use.</p><h4>Pharmacokinetics</h4><p>No human pharmacokinetic data available in the existing literature. PK parameters estimated using generic assumptions for small molecule oral exposure in adults.</p><h4>References</h4><ol><li><p>Seth, PK (1982). Hepatic effects of phthalate esters. <i>Environmental health perspectives</i> 45 27–34. DOI:<a href=&quot;https://doi.org/10.1289/ehp.824527&quot;>10.1289/ehp.824527</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6754361/&quot;>https://pubmed.ncbi.nlm.nih.gov/6754361</a></p></li><li><p>Kremer, JJ, et al., &amp; Borghoff, SJ (2005). Pharmacokinetics of monobutylphthalate, the active metabolite of di-n-butylphthalate, in pregnant rats. <i>Toxicology letters</i> 159(2) 144–153. DOI:<a href=&quot;https://doi.org/10.1016/j.toxlet.2005.05.006&quot;>10.1016/j.toxlet.2005.05.006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15994034/&quot;>https://pubmed.ncbi.nlm.nih.gov/15994034</a></p></li><li><p>Yuan, J, et al., &amp; Li, S (2014). Oral sustained-release suspension based on a novel taste-masked and mucoadhesive carrier-ion-exchange fiber. <i>International journal of pharmaceutics</i> 472(1-2) 74–81. DOI:<a href=&quot;https://doi.org/10.1016/j.ijpharm.2014.05.048&quot;>10.1016/j.ijpharm.2014.05.048</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24882038/&quot;>https://pubmed.ncbi.nlm.nih.gov/24882038</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end P03BX03;
